A university research team had worked for a number of years on the development of a novel interventional cardiology device. Recent progress had been made with preclinical testing on pigs, as well as a collaboration with a leading medical device company. This recent activity led the university to seek clarification on the status of the project from a third party with specialist expertise. The team needed a reality check on the status of the project, including current activities and a top-level sanity check on its technical feasibility.


We conducted the following to meet the objectives of the assignment:

  • Technical expert review of the history of the project, its current status, the principles and technologies behind the product concept(s), and the clinical implications of the proposed innovation.
  • Desk research, drawing upon public domain information and our databases.
  • Interview with an interventional cardiologist to gain their views on the deficiencies of existing devices and the need for improvements in performance.
  • A top-level review of the technical feasibility of the proposed concept(s) to highlight any potential red flags on performance or manufacturing.

Explore Our Due Diligence Services

Alacrita's due diligence consultants have been a trusted source of pharma and biotech DD for over 15 years, underpinned by our ability to ensure each due diligence exercise is supported by individuals with the precise industry expertise required to be thorough, complete and accurate. 


Related Case Studies